Podcasts about medical technology

My guest today, Kit Karson, is the author a series of books, The Anderson Chronicles: A Sheriff Elliott Mystery, which currently comprises five novels, including: Land Grab, Innocence Slain, Justice Rendered, Nefarious Intent, and Savage Malice. All five take place in a small Montana town. Interestingly, as prolific as Kit is as an author, writing is not her principal occupation.Born and raised in the mountains of western Montana, Kit spent her childhood traipsing around forests, streams, and meadows, either on foot or horseback, exploring, fishing, and shooting. After earning undergraduate degrees in Medical Technology and professional Microbiology, she ultimately earned a Master of Science from the University of North Dakota. Subsequently, Kit spent more than 3 decades under a microscope as a medical technologist and lab manager for various medical, hospital, and health care facilities. She's currently a laboratory director at Granite County Medical Center. I've read Nefarious Intent, the 4th book in the Anderson Chronicles Mystery series, and can tell you it's an engrossing, page-turning thriller that kept me wanting to know how the intricate puzzle would unravel.  If you like mysteries set outside of urban landscapes, I highly recommend Kit's books to you.Kit's website: https://www.kitkarson.comFacebook: facebook.com/kitkarsonauthorTwitter: twitter.com/kitkarson11

Was macht das Innovation Forum Medizintechnik - veranstaltet von MedicalMountains GmbH, TechnologyMountains e.V. und IHK Schwarzwald-Baar-Heuberg - zu einem der wichtigsten Branchentreffs in Deutschland? Wer entscheidet über die Keynotes, wie laufen Planung und Organisation im Hintergrund – und welche Geschichten passieren abseits der Bühne? In dieser Folge von MedTalk on Air nimmt euch Julia Steckeler mit hinter die Kulissen eines Events, das mehr ist als Messe und mehr als Kongress. Zu Gast sind Britta Norwat, verantwortlich für Programm und Inhalte, sowie Marena Rothermund, die die Ausstellung und das Ausstellererlebnis mitgestaltet. Gemeinsam geben sie exklusive Einblicke in Planung, Teamarbeit und kleine Geheimnisse rund um das Forum. Themen sind u. a.: • Was das Innovation Forum auszeichnet – und für wen es gemacht ist • Wie das Programm entsteht – von der ersten Idee bis zur Keynote-Zusage • Warum die Ausstellung inzwischen innerhalb von 24 Stunden ausgebucht ist • Was hinter den Kulissen wirklich passiert – inklusive Anekdoten • Persönliche Highlights und Vorfreude auf 2025 Tipp: Das Innovation Forum 2025 findet am 23. Oktober in Tuttlingen statt. Infos & Tickets unter https://medicalmountains.de/innovation-forum-medizintechnik/

Dr. Adam Power, co-founder and Chief Medical Officer at Front Line Medical Technologies, shares his fascinating journey from a background in vascular surgery to developing COBRA-OS, a groundbreaking device for hemorrhage control. He discusses the challenges and milestones in bringing this life-saving technology to market, the impact of the device in trauma and emergency care, and innovative future applications, including its unexpected use in non-traumatic cardiac arrest.    Guest links: https://frontlinemedtech.com/ Charity supported: Canadian Cancer Society Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 064 - Dr. Adam Power [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Dr. Adam Power. Dr. Power is a leader in innovative medical devices for trauma and emergency care that is committed to lowering the barriers and bleeding control and resuscitation. Dr. Power was instrumental in the development of COBRA-OS, drawing on his unique clinical viewpoint and expertise to ensure utmost patient safety and assist with the company's global expansion. In addition to his current role as co-founder and Chief Medical Officer at Front Line Medical Technologies Incorporated, Dr. Adam Power is a vascular surgeon in the division of vascular surgery at Western University, which he joined in the fall of 2012, and he is involved in all aspects of academics and clinical care. Also, Front Line was just named the 2025 Medical Device Technology Company of the Year, so I definitely wanted to highlight that too. All right. Well, thank you so much for being here today, Adam. I'm so delighted to speak with you. [00:01:55] Dr. Adam Power: Yes, it's a pleasure to be here. Thank you. [00:01:57] Lindsey Dinneen: Of course. Well, I'd love if you would start by sharing a little bit about yourself, your background, and what led you to what you're doing today. [00:02:05] Dr. Adam Power: Sure, I'd love to. So I'm a Canadian. I grew up on the east coast of Canada and was always interested in science and math and those types of things. I think, importantly, I grew up with an identical twin brother as well. So we really didn't know what we wanted to do with our lives, and ultimately we're good in science and math and ended up in medicine. And then both of us, when we got into medicine, we weren't sure exactly what we wanted to do in medicine, and ultimately both of us became surgeons. He became a urology surgeon, and I became a vascular surgeon, where we joke that we're both plumbers. I deal with the red stuff and he's the yellow stuff. But I did my initial medical school out on the east coast of Canada and then I did my general surgery training, which also involved trauma training, and then did a Master's of Bioscience Enterprise, which was basically biotech business from the University of Cambridge in the UK. When I finished my general surgery training, I continued on and did vascular surgery training at Mayo Clinic down in the US, and since that time after graduating from there, I've been at Western University in London, Ontario, Canada, for the past 13 years practicing as a vascular surgeon and an academic vascular surgeon. But when I was here at Western, I was always interested in innovation. I filed my first patent as a resident way back when, and have filed many over the years. But ultimately, if I was ever gonna see anything that came outta my head and was actually used in a patient or I could actually use in a patient, I figured I'd have to do it. I knew that I couldn't do it by myself. And so, I was very fortunate to meet my co-founder Dr. Asha Parekh. She's a PhD, biomedical engineer, extremely smart jack of all trades, and we teamed up now about eight years ago. We met here at Western, teamed up and really took an idea right out of our heads and patented it and raised money for it, prototyped it, brought it all through the regulatory steps to approvals, built a quality system and ultimately got it out onto the market in Canada, US, Europe, now Australia, and more to come. So the commercialization piece is what we've been focusing on over the past three years. And it's been really fun, but very exhausting but very rewarding as well. I think I'll stop there because I've been blathering on, but... [00:04:39] Lindsey Dinneen: No, it's fantastic. I really appreciate it. Plus, it's really fun to hear about your trajectory and so, okay, so you've teased us a little bit about this company of yours and this innovation of yours. Can you now share a little bit more about that and the development of it over time? [00:04:55] Dr. Adam Power: Yes, of course. Well, I mean, thing that we recognized early on is, and I'll just explain how I normally explain it, is if you have bleeding, it's a hemorrhage control device. And so if you have bleeding in your extremities, then you can often either put pressure on it or you can put a tourniquet on it. The problem when you have internal bleeding in the torso is that you can't actually put direct pressure on it, and there's no tourniquet that necessarily works for intraabdominal, intrathoracic bleeding. And when people bleed to death before coming to hospital, I mean, they're bleeding in these areas. You can empty almost your entire blood volume into your chest or into your abdomen. And this does account for a significant number of fatalities in all environments, basically in the trauma environment. That's military, that's pre-hospital, that's any time that that people are bleeding from internal organs. And so, because this is such a problem, the old fashioned way to fix it is to open up someone's chest and put a clamp on the aorta. So what does that do? Is it basically above the clamp, keeps blood flowing. The remaining blood in the body keeps blood flowing to the brain and the heart, keep you alive. And then below the clamp, it stops sort of the hemorrhaging from the spleen or the liver or whatever. So there's two things going on. One above the clamp and two below the clamp. But opening up somebody's chest in, you know, side of the road or in the emergency department really is impossible. You need highly skilled people like vascular surgeons like myself to be able to do this. And even if we were at the side of the road, we don't have the resources available to keep a patient alive. So there is this idea that we could do this minimally invasively, sort of accomplish this through minimally invasive means. And this, the idea of doing REBOA, which is an acronym-- Resuscitative Endovascular Balloon Occlusion of the Aorta-- came into being. This was probably 15, 20 years ago now. It wasn't necessarily a new idea. It had been done since the Korean War. There was somebody actually put a balloon up into someone's aorta to stop bleeding, but it came back again and was starting to be used a little bit more because. And so really the idea is to, through the femoral artery in your groin where you can feel a pulse, you introduce initially a sheath, which is your access point, and then you place the device up through the sheath, up into the aorta and inflate a balloon in the aorta. So instead of an external clamp, it's an internal balloon clamp that keeps blood flowing above the balloon and stops the blood flowing from below the balloon. Initially these devices were as big as my baby finger, like they were massive. And so if you put them in and you took it out, there was a big hole in the artery, had to cut down on the artery and repair the artery. But as it got more and more advanced and technology advanced, they become smaller and smaller. So that's really where we came in. The initial devices were 12 French, about the size of my baby finger. And then it advanced to Seven French and all of a sudden Seven French-- and these are diameter, French sizes are basically diameter-- and so when it went from 12 to seven French, now we could start doing it through the skin without actually cutting down on the artery. But that Seven French size was still very large and you're putting this in the hands of people that don't do this all the time. And so, we had the idea to bring it down even further now to Four French. And so this is essentially the size of an IV. And so you put a tiny little IV in somebody's femoral artery. And lots of different people can do that. And then you advance the device up in, inflate the balloon and you can magically occlude the aorta. In our first study that we did, the first inhuman study, we averaged about just over a minute to occlude someone's aorta, which was really fast to be able to get that amount of control that quickly. So that, that was really been the advancement is to decrease the access size, make this whole procedure simpler so that so that we can essentially save more lives. [00:09:08] Lindsey Dinneen: Okay, so thank you so much for sharing a little bit about that. Can you tell me about the beginnings of this innovation and how you brought it to market? Because it's really wonderful to hear all the success, and I'm so excited to hear that it's spreading, you have presence all over the place now. But you know, that's not an easy pathway. And I'm curious if you could walk us through a little bit about that decision to go, "You know what? We have a solution to a known problem, we can make this happen." And then how did you actually go about doing that? [00:09:42] Dr. Adam Power: Yeah. I think, I mean, I make it sound fairly straightforward, like a nice story, but it certainly was not that. I mean, we were very lucky I would say, that we had a lot of great advisors and mentors that we figured that we try not to fail early, fail fast. We wanted to make this one as successful as possible. So before we made any decision, we often would consult our mentors. And I'm a surgeon. I like to shoot first, ask questions later. My partner is not. And so I think we, we strike an excellent balance between not just the engineering and clinical side of things, but also from driving a business forward, getting all the information, but helping to get decisions made and moving forward. You know, starting out, we really had to choose the right sort of fit for what we wanted to pursue. We like to say it checked all the boxes. It checked all the boxes as far as even where we are. We're in Canada, we're not in a tech triangle where there's tons of funding opportunities. We knew we would be limited from a funding perspective, so we couldn't choose something that necessarily required a hundred million dollars to start up. So, you know, we had this device that we knew that we could fundraise for it. And then once it was fundraised, it was simple enough that we could get it manufactured. We chose to go the OEM route for the original equipment manufacturer, so we didn't have to build a manufacturing facilities ourselves. And then really from there, and building a quality system in the regulatory, we did work with a lot of consultants, that was both positive and negative experience. We had great consultants. We had not so great consultants. But really what our our goal was, is to learn the process ourselves. And so there's always manuals for things, even from the FDA perspective. They give out great documentation about what is supposed to go into an FDA application. And we dug into that. We really tried to understand. We did not trust anyone. That's one of my rules in surgery is, "don't trust anyone, not even myself." So we really didn't trust our consultants, and we tried to double check and triple check everything so that we didn't make mistakes. And of course, we did make mistakes and had to go back to the drawing board a few times. But as much as we wanted to get this out there, we really did wanna learn the process and know the process because ultimately we're the ones that are responsible to the patients in the end, and we needed to make sure that we had a handle on each and every step of the way. We, of course, because of that, were maybe not as quick as we could have been but in other places we became more efficient because, as we learned the process, getting feedback back and doing it right the first time, it really made a difference. So. [00:12:39] Lindsey Dinneen: Yeah, absolutely. Of course. Yeah, and I appreciate you going into a little bit more of the nitty gritty details 'cause it is so fun to hear the success stories, but of course, as you go along, there's that pathway to success. And it's helpful to understand that yeah, it's gonna be potentially a long road, sometimes windy, sometimes weird, but at the same time that it is possible. So as you look to the future with your company, what are you thinking of in terms of the future? Are you going to continue down this pathway and continue with iterations of this device? Are you thinking of new devices to introduce as well? Or, what are your thoughts for the future? [00:13:18] Dr. Adam Power: Yeah. And I have to be very careful what I say here, obviously. I can share generically what our thoughts are. We love this. Ultimately there was no better feeling than to use-- I mean, I've used my device to save a patient. And, you know, I would say that Asha, who's my co-founder, she cares. I'm a physician, but she cares about the patients just as much as I do, as does everyone in our company, which is really quite rewarding. But the future, what does the future hold? We really want this to get to everywhere. Yes, we're in lots of different countries ,have commercialized really all around the globe, but we really wanna go deeper into a lot of these geographies and really help as many people as possible. We realize that we can't do it on our own and are gonna need help. And so that's, we're in a growth phase right now of our company and we're looking for strategic collaboration. We're looking for those opportunities to deepen our ties and in all the different geographies. That being said, we are inventors and of course we have an idea every day about what we could improve on. But as far as the pipeline goes for our company, we are focusing on some very specific up and coming applications that we hope to have in the next couple of years. And I also wanna say that, I talked about trauma and bleeding, but the more exciting side of aortic occlusion has really been the applications. And you'd think, okay, it makes sense for trauma to be able to stop blood flow and stop bleeding. But some of our recent successes have been through postpartum hemorrhage. And there is this really, terrible condition called placenta accreta, where the placenta grows into the uterus and when you deliver the baby either by C-section or by delivery, and then the placenta attempts to be delivered, it tears, and you can have torrential bleeding. And, and so our device is being used in these women who are pregnant when inflicted with this condition and helping to decrease blood transfusions, helping to save a mother's life. So that's been really amazing. And then next on the horizon is strangely there's, it's not even a bleeding application. We've done some research and there's research going on globally about using aortic, minimally invasive aortic occlusion for non-traumatic cardiac arrest. And so if, which is really, again, it's like, "Oh my gosh, does this thing do everything? It might make your supper tonight if you're not careful." So it, so what happens there is that if somebody drops dead basically in front of you, and you start CPR, if you start pushing on their chest and pushing on their heart, you're pushing blood to the whole body. And the way you get someone back to life is if you can get the heart muscle oxygenated again. So if you put an aortic occlusion balloon up close to the heart, every time you push, you're directing blood right into the coronary arteries and right into the brain as well. And so what we're seeing is that there's increased return of spontaneous circulation rates when you do this with CPR. And there are different trials around the world that if this shows that there's an increase in survival or in better neurological survival, this will be the first time that we've really changed the script on cardiac arrest since advanced cardiac life support came out many years ago. So this, again, is very exciting for a simple device to be able to make that much impact in all these different areas. So, you know, we have a lot to focus on right now, even growing into the future because some of these, like cardiac arrest, are quite early on. So we don't wanna lose sight of this great original product, but we do think all the time about different pipeline ideas that could help other patients. [00:17:18] Lindsey Dinneen: Yeah, but, and to your point, even the amazing other use cases for this incredible device, like you said-- maybe it's gonna make us dinner next-- but the idea being that, who knows? I mean, there's so much more to discover even now, which makes me excited just to think about how many more use cases you could have for it and how many more people you could save. So, speaking of that, are there any stories that kind of stand out to you, moments that you've had where, you know, either through your day job, so to speak, being a vascular surgeon, but also being the co-founder of this company that really sort of affirmed to you that, "You know what? I am in the right place at the right time, in the right industry." Just those moments that really stick with you. [00:18:05] Dr. Adam Power: Yeah, I mean, it obviously all stems back to the patient and what patients are impacted. And I remember, the first time that the device was used at our hospital, one of the radiologists called me in and said, " We need to use one of these balloon occlusion devices for a patient that's been in an accident." And so I went in and I said, "I actually have the device that my partner and I created. We can use this for the patient." And so we started using it for the lady that was involved in a very serious accident, had a pelvic fracture, and she was a Jane Doe at that particular time. She was anonymous. And anyway, we noticed that she had actually had some vascular surgery done based on her angiograms, and I leaned over and I-- so she was sedated, but she was awake-- I said, "Have you had vascular surgery? Who's your vascular surgeon?" And she said, "It's Dr. Power. He's such a nice man." And so I was actually helping one of my patients. That was pretty crazy. [00:19:04] Lindsey Dinneen: Oh. [00:19:05] Dr. Adam Power: Also from my hospital, when I heard one of my junior residents was able to save someone's life. So, you know, junior residents are often good, but they're not trained surgeons. And so to have a simplistic device that one of my residents could actually place and help someone, that's pretty amazing too. There's also been times where like even the postpartum hemorrhage, we hear the first cases in the States of saving mother and baby. That's pretty incredible. Or that we donated some devices to the Ukraine conflict as well, and we heard that it saved some soldiers' lives as well. And there's different military groups that, that use our device and save soldiers. So it's all back to the patient. And hearing those success stories and hearing about somebody alive because of this particular device, because of all this effort that we've put in. I mean, it's really makes it worthwhile. It sounds kind of corny, but as a surgeon, I can help one person at a time, but as somebody involved in industry and medical device industry, I don't even have to be there. You know, this device can help long after I'm gone. The tricky part of it, being the Chief Medical Officer is, I usually only have to worry about my patients. Now I have to worry about everybody worldwide and the device being used. That was a little hard to wrap my head around initially, but yeah. [00:20:28] Lindsey Dinneen: Yeah, of course. But the ripple, the ripples, the impact that you get to have because of this device and because of your diligence getting it to market, because it isn't an easy path, and that's incredible. So thank you for doing the work that you're doing. That's not easy and it's very appreciated. This is incredible. So, yeah. So, okay. When you were growing up, let's say 8-year-old, Adam-- you know, you're having a good time doing whatever you like to do-- could you possibly have pictured yourself where you are now? [00:21:08] Dr. Adam Power: No, I don't think so. I mean, I, I. I came from a very small, like, small upbringing and, you know, in my family I had absolutely lovely family members, but they really, apart from my aunt, they weren't overly educated. And so I really didn't know what it took to be successful in life, really. I had work ethic from my parents, that's for sure. And so that's what they bred into me. And all I knew is that I was gonna work as hard as I could, and I figured that as long as I keep working-- and I was lucky to have some brains as well-- then I figured things would fall into place. They honestly haven't fallen into place exactly how I pictured them as I grew older and what it would look like. But I'm certainly thankful for where I am right now, and what is the next five years or 10 years gonna look like? I have no idea. And I guess I just don't even picture it. I have goals, but I also know that those goals change depending on circumstances. And you need, as I'm growing into middle age-- I think I'm beyond middle age now-- I'm thinking about midlife crisis and things like that. I get into philosophy and there's like telic and atelic things and so, it's sounds, again, it's about the path and the journey. It's not about the ultimate goal because, having reached a lot of these successes, that good feeling lasts for maybe a day or half a day. And you think you know, I spent all these years coming with the, with our device, getting our device to market and getting FDA approval and like, oh my gosh, like, you'd think, I'd feel so great about that. And it did. It felt great, but you wake up the next day and you gotta keep going. So you have to enjoy the journey and that's really what it's the wisdom that comes with age is trying to enjoy the journey as much as possible and not focus too much beyond that. [00:23:09] Lindsey Dinneen: Yeah. Yeah, and I think that's really good advice too, in that it is because the daily life isn't usually all the celebration and successes. I mean, that does happen and those are good moments, but because the vast majority of our life is spent on the journey component of it, and going through those peaks and valleys, it is important to find something you love and feel that you can make an impact in. So I'm so thankful that this is what you've chosen to do. So pivoting the conversation a little bit just for fun, imagine that you're to be offered a million dollars to teach a masterclass on anything you want. Could be within your industry, but it doesn't have to be. What would you choose to teach? [00:23:55] Dr. Adam Power: And would that mean that I was an expert in it? [00:23:58] Lindsey Dinneen: Well, certainly if you're getting paid a million dollars, somebody has decided you aren't an expert at it. How about that? [00:24:05] Dr. Adam Power: Okay. Well. Can I pretend like I'm an expert in it? There's something that I really love, but I'm not I'm probably not an expert in it. It would be, I would teach a masterclass in DJing. Isn't that strange? I know it's so random. [00:24:21] Lindsey Dinneen: Oh my goodness! Tell me more! [00:24:23] Dr. Adam Power: Well, I mean, I love music. I've, I grew up playing lots of sports and never was involved in music. And, and I've always appreciated music and art, but I was never able to do it. And, you know, growing up I did love sort of all types of music and then even electronic music and it just somehow talked to me. So I started DJing electronic music basically when I was around med school and have always loved it now, and when I was over in England, I DJ'ed on the campus radio and also DJ'd in a club. It was really fun and it sounds pretty silly to be talking about this when I have these other things that are on the go. But honestly, being able to share space with other human beings these days, and actually having a good time and having it not be stressful and having it be only, you know, everybody's wishing others to have a good time. There's not many people that go out sort of dancing into electronic music that are thinking bad things about other people. Really they're just out for a good time. And so being able to steer that whole music and scene is pretty awesome. And I do love it. And I don't DJ as much as I used to, but I still do different events, usually Christmas parties for the operating room. I'll do the typically wedding sort of DJ, but then they always, 'cause they know me, they let me do an hour long electronic set, which is like hardcore electronic. But then I go back to the regular stuff. But I would want to teach a masterclass in DJing. [00:25:56] Lindsey Dinneen: That is awesome. How exciting. Oh my gosh, I love that. And I think you're right. Music brings us together and it's a wonderful way to, to share a little bit of joy. [00:26:07] Dr. Adam Power: Yeah. [00:26:08] Lindsey Dinneen: Yeah. Okay. And then how do you wish to be remembered after you leave this world? [00:26:15] Dr. Adam Power: I, so number one is I don't, again, with my midlife crisis, I've actually been trying to eliminate my ego as much as possible. And so when people talk about legacy, it actually gives me the hives these days to be quite honest, because I don't like that because I think you're focused a lot on yourself. In my opinion, a lot of legacy is all about you. The way that I would wanna be remembered, though, is truly that I was kind and compassionate to everyone that I met, and that I stood for something, and that I left the world a better place. [00:26:57] Lindsey Dinneen: Yeah, those are wonderful things to want to be remembered for, absolutely. And then final question, what is one thing that makes you smile every time you see or think about it? [00:27:09] Dr. Adam Power: My kids. My son Kai and my daughter Saoirse. They are the light of my life. And I, you would think that with how busy I am ,you know, those things would deprioritize, but they truly are the one thing in my life that makes me smile when I get up in the morning. [00:27:30] Lindsey Dinneen: Oh, that's wonderful. Well, that is absolutely incredible. I loved getting to meet you and speak with you a little bit today. Thank you so much for sharing about your journey. Thank you for sharing about your incredible device and your bits of wisdom along the way. The idea of we've gotta enjoy the experience, the path, the journey. And I just really appreciate you spending some time with us. So thank you for everything you're doing to change lives for a better world. [00:27:59] Dr. Adam Power: Oh, well, thank you for giving me the opportunity to speak with you. It was absolutely lovely chatting with you today. [00:28:05] Lindsey Dinneen: Wonderful. Well, thank you again so much. Thank you also to listeners who are tuning in, and if you're as inspired as I am, I would love it if you would share this episode with a colleague or two and we'll catch you next time. [00:28:20] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Welcome to Episode 206 of the Tangential Inspiration Podcast. It has been a difficult week here in the United States, so the perfect time for inspiration. Let inspiration act as a beacon of light in the darkness, and let hope overcome fear. We have three great stories for you. First, there is a woman who is making a huge difference in the lives of the homeless people in her area, then there is a story about how important it is to support colleges and universities as they make huge advances in medical science, and finally, a story about a former rugby player who continues to ascend to greater heights following a devastating injury. There is something for everyone in this episode, let's get inspired!#BeKind#WeStandWithUkraineWe would love to hear from you. Send us your comments or even your own inspirational stories at tangentialinspiration@gmail.com.Follow us on our social media:Instagram: tangentialinspirationpodcastFacebook: https://www.facebook.com/tangentialinspirationTwitter: https://twitter.com/TangentialInsp1Produced and Edited by Craig Wymetalek Hosted on Acast. See acast.com/privacy for more information.

On this episode of Skin Anarchy, Dr. Ekta sits down with Alain Dijkstra, CEO of Nuon Medical Technologies, to explore how medical-grade devices are redefining the future of skincare and beauty. With two decades of experience innovating in the medical device space, Dijkstra has transformed his expertise in surgical lighting and operating room technology into consumer-friendly tools that bring science-backed results straight to our vanities.At the center of his vision is light therapy—an area backed by thousands of clinical studies and proven benefits ranging from skin rejuvenation to wound healing. Unlike many treatments, it offers visible results with minimal side effects, making it one of the most exciting frontiers in beauty tech. But for consumers, safety and efficacy remain key, which is why FDA-cleared devices are at the core of Nuon's mission.What makes Nuon truly groundbreaking is its approach to integrating technology directly into cosmetic packaging and everyday routines. Imagine a spatula or applicator that not only applies your cream but also delivers light therapy, improves absorption, and gives you real-time feedback on your skin's hydration and oil levels. It's a step beyond skincare—it's turning daily rituals into measurable, tech-driven treatments.For beauty brands, this shift presents enormous opportunity. Devices don't replace serums and creams; they enhance them, driving better results and deeper customer loyalty. As Dijkstra explains, the future of beauty is already here—and it's powered by innovation that bridges the gap between medicine and cosmetics.To learn more about Nuon Medical, visit their website and social media. CHAPTERS:(0:00) Introduction & Guest Welcome(1:39) Alain's Background(3:29) Founding Nuon Medical & 20 Years of Device Innovation(4:25) Light Therapy Benefits & Expanding Applications(7:01) Evaluating Good vs. Bad Light Therapy Devices(10:31) Brand Integration Challenges & Case Studies(16:17) Active Applicators & The Future of Cosmetics(19:04) Skin Diagnostics, Feedback & Consumer Retention(25:05) Miniaturization & Technology Advances(27:35) AI, Precision Treatments & The Next FrontierPlease fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf! Hosted on Acast. See acast.com/privacy for more information.

Cybersecurity has become one of the defining priorities for a digitally advanced healthcare system. With hospitals and healthcare providers increasingly reliant on connected technologies, ensuring resilience against cyber threats is more critical than ever.​ In the latest episode of MedTech ON AIR, we sat down with Benjamin Meany, MedTech Europe Senior Manager for Digital, Software and AI Regulation, to discuss how the medical technology sector is addressing these challenges. ​ From ransomware attacks that disrupt hospital services to the theft of sensitive patient data, cyber threats pose real risks to patients, healthcare professionals, and health systems across Europe. In this episode, we explore the growing impact of cybersecurity incidents on European healthcare and how they are reshaping the way hospitals, professionals, and patients experience care.​ Listen in as we discuss with Benjamin what needs to happen to better protect healthcare infrastructures and reinforce the digital resilience of the European health ecosystem. Learn more about cybersecurity: https://www.medtecheurope.org/digital-health/cybersecurity/ ​

We've long marveled at how efficiently plants convert sunlight into energy—but no one guessed they were using quantum mechanics to do it.In this episode, we speak with Greg Engel, a pioneering University of Chicago biophysicist who helped launch the field of quantum biology. Engel explains how plants and bacteria evolved to exploit quantum effects for photosynthesis—and how understanding these systems could spark a revolution in quantum sensing, medicine, and neuroscience.Engel's team has already built quantum sensors inspired by nature's designs, with the potential to transform how we detect disease, develop drugs, and even read neural signals. The ultimate goal? A new era of quantum medicine, powered by the weird and wonderful physics found in leaves.

Join us for an empowering conversation with Rachel Weissberg, a trailblazing woman in healthcare IT who has shattered glass ceilings while driving double-digit growth for Fortune 1000 companies. As Head of Healthcare Provider Strategy at Neteera and influential leader at HIMSS and CHIME, Rachel shares her journey from psychology graduate to C-suite advisor, revealing how women can leverage their unique strengths to build authentic partnerships in a male-dominated industry. Discover her Southern California approach to relationship building, why she champions partnerships over traditional selling, and practical strategies for women advancing in healthcare IT leadership. This episode offers invaluable insights for women at every career stage, plus actionable advice for male allies looking to support gender diversity in healthcare technology.Rachel Weissberg, Head of Healthcare Provider Strategy, NeteeraMegan Antonelli, Founder & CEO, HealthIMPACT Live

Is gentle rebounding and indoor recumbent biking safe for someone with chronic venous insufficiency?Were you talking about 'disseminated sarcoidosis'?What are your thoughts on AI-enhanced EKGs?What can I do to find relief for my irritable bowel syndrome?Are there benefits to chelation therapy, or has it fallen out of favor?Some brands of stevia don't contain erythritol.  Can I use those?

Todd Crowder, one of the most respected leaders in medical sales, joins Samuel Adeyinka to break down the mindset and daily habits that separate long-term top performers from everyone else. Together, they reveal why the toughest challenges in your career aren't obstacles to avoid — they're opportunities to train, grow, and dominate your market. We explore why comfort kills sales careers and how the best reps deliberately seek discomfort every single day. Todd shares his “ABC” strategy for managing priorities, staying ahead of competition, and building a pipeline that never runs dry — whether you're in your first year or your 25th. You'll learn how to reframe “hard times” as training grounds, develop the resilience to perform under pressure, and prepare for the higher stakes that come with success. From handling setbacks without emotion to finding 1% improvement every day, Todd delivers a masterclass in staying relevant and unstoppable in medical sales. If you want to compete with — and outlast — the best in this industry, this episode will give you the mindset, process, and tools to make it happen.   Connect with Todd: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

Join host Megan Antonelli as she sits down with Melissa Medina, Co-Founder & CEO of eMerge Americas, to discuss the landmark partnership that's reshaping healthcare innovation. From transforming Miami into a global tech hub to launching the most dynamic health platform in the Americas, Melissa shares insights on cross-sector collaboration, venture capital trends, and why Florida is becoming the epicenter for breakthrough healthcare solutions. Discover how eMerge HEALTH 2026 will unite payers, providers, policymakers, and innovators to drive real-world impact across AI, precision health, and health equity initiatives.Melissa Medina, Co-Founder and CEO, eMerge AmericasMegan Antonelli, Founder & CEO, HealthIMPACT

Choosing the wrong medical sales role is one of the biggest reasons professionals burn out or walk away from the industry. In this episode, Samuel Adeyinka breaks down exactly how to avoid that mistake — and how to find the medical sales specialty that actually fits your personality, lifestyle, and long-term goals. Medical sales isn't one-size-fits-all. From trauma reps in the OR at 3 a.m. to pharmaceutical reps building slow-burning relationships, this episode unpacks the real differences between specialties — and how those differences directly impact your happiness and success. Samuel shares four powerful questions to ask before applying to any role, helping you get clear on your ideal lifestyle, how you like to build relationships, your appetite for clinical depth, and whether you're built for building new business or growing existing accounts. You'll also learn what hiring managers are really looking for, why desperation kills your chances, and how the wrong fit leads to fast burnout and industry ghosting. This episode is packed with real talk, strategic insight, and a roadmap to make smarter career decisions from the start. If you're serious about getting into medical sales, stop guessing. Message Samuel on LinkedIn with the word podcast to get access to MedSales Match — the free tool that helps you find the specialty made for you and unlock your next move. Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

Unleashed: The Political News Hour with Susan Price – Discover how Dr. Stan Pierce, known as the “Elon Musk of Chiropractic Innovations,” is transforming pain relief with EPIC, a groundbreaking sound wave technology for upper cervical care. Dive into a world where technology meets health, eliminating guesswork, and creating real results for patients from around the globe. Experience a revolution in healing and wellness today...

In the first of a four-part collaborative series with the Medical Technology Association of New Zealand, eHealth Talk host and HiNZ media editor Rebecca McBeth interviews MTANZ CEO Cushla Smyth about the challenges facing medical device suppliers and the future of the sector.They discuss findings from MTANZ's latest member survey, procurement delays, the lack of clarity over whether Pharmac or Health NZ will manage medical device contracting, and what this uncertainty means for investment and patient access to new technologies.Cushla also shares her vision for building a thriving, patient-focused medical technology industry in Aotearoa.

As healthcare technology leaders navigate an increasingly crowded digital landscape, the temptation to leverage influencer marketing for B2B reach is growing. However, healthcare's unique regulatory environment and trust requirements demand a fundamentally different approach. Join Megan Antonelli as she reconnects with fellow Vassar alumna Danielle Wiley, founder and CEO of Sway Group, to explore why most sponsored content fails healthcare organizations and how to build authentic, compliant influencer partnerships that drive real clinical adoption and stakeholder trust in our post-platform world.Build authentic influencer partnerships based on genuine product experience to create content that actually drives B2B conversions.Shift from platform-dependent strategies to owned media relationships as social algorithms become increasingly unpredictable.Focus on long-term brand advocacy over transactional sponsored posts to maximize ROI in professional service markets.Leverage LinkedIn's professional network strategically by partnering with industry experts rather than chasing generic engagement metrics.Danielle Wiley, Founder & CEO, Sway GroupMegan Antonelli, Founder & CEO, HealthIMPACT Live

Explore the future of healthcare in India with Vishal Lathwal, CEO of Apollo HomeCare. Uncover the booming Indian home healthcare market (projected to hit USD 64.4 Billion by 2033), a vital solution for hospital bed burden and high costs. Learn how Apollo HomeCare delivers integrated home healthcare services, including skilled nursing care, physiotherapy at home, post-operative care, and chronic disease management like diabetes and stroke recovery. Discover advanced medical technology enabling ECGs at home, X-rays at home, and remote patient monitoring, enhancing patient outcomes and family peace. Understand home healthcare costs in India (₹1,000-₹4,000/day, or ₹30,000-₹60,000+/month for caregivers/nurses) and challenges in health insurance coverage for domiciliary hospitalization. Discuss the impact of telemedicine, AI in healthcare, and wearable health technology on personalized care. Gain insights into career opportunities in home healthcare, driving a more compassionate society. Essential for those interested in elderly care, patient-centric healthcare, digital health solutions, and healthcare delivery models in India. Key Takeaways:✅ Massive growth of Indian home care market & its benefits.✅ Apollo HomeCare services, pricing, and health insurance coverage.✅ Impact of technology in home healthcare & career paths....#HomeHealthcare #IndiaHealthcare #ApolloHomeCare #HealthcareAtHome #PatientCare #HealthInsurance #MedicalCosts #ElderlyCare #ChronicDiseaseManagement #Telemedicine #DigitalHealth #AIinHealthcare #HealthcareInnovation #IndiaGrowthStory #HealthcareTrends #NursesAtHome #PhysiotherapyAtHome #PostOperativeCare #AffordableHealthcare #InvestingInHealth #IndianEconomySee omnystudio.com/listener for privacy information.

Logan, a distinguished leader in the medical sales industry, joins us to share her unconventional journey, from pre-med student to CEO in neuromonitoring, and later, to a hands-on role in spinal device sales. Her story is a powerful example of how diverse experiences can shape a well-rounded, impactful career in medtech. Logan offers key insights into the role of neuromonitoring in surgery, the risks of false positives, and the critical communication needed between OR teams. We explore the often-overlooked dynamics between neuromonitoring techs and device reps inside the OR. Logan pulls back the curtain on how strong reps build trust, stay composed under pressure, and keep patient care at the center, even when tensions rise. Her perspective reveals why emotional intelligence and accountability are non-negotiables for long-term success. Logan's transition from the C-suite back into the field brings a rare perspective on leadership and growth. She reflects on the humility and reward of working directly in surgical settings, the realities of financial motivation in healthcare, and the silos that still exist between clinical and commercial roles. Her take on leadership is clear, great managers must coach, delegate, and develop others if they want their teams to thrive. Whether you're in the OR, aiming for the executive suite, or somewhere in between, Logan's story is packed with insight, reflection, and hard-earned advice on how to grow a purpose-driven career in medical sales. Connect with Logan: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

As drug abuse rises globally, organizations and governments are turning to preventive solutions. With over 450 active accounts across 24 countries, Intelligent Bio Solutions (Nasdaq: INBS) is making a significant impact through its Intelligent Fingerprinting Drug Screening System.In this interview, Doug Heath, VP of Global Sales, and Anna Turkington, VP of Marketing, discuss how the company is advancing portable, rapid, and pain-free drug testing using its fingerprint-based screening technology.They also share insights into Intelligent Bio Solutions' business model, growth outlook, market opportunity, and global expansion strategy.Find out more: https://ibs.inc/Watch the full YouTube interview here: https://youtu.be/qHeVoWcBU_U And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1

In this episode, special guest Todd Crowder joins Samuel to unpack what it really takes to develop transformational leaders in medical sales. Together, they explore how proper management training and mentorship can unlock the full potential of a team, and directly impact revenue, culture, and long-term growth. We dig into the often-overlooked transition from top-performing rep to successful manager. Todd shares how to empower new leaders to think like CEOs, embrace strategic thinking, and handle hiring with confidence. If you've ever struggled with promoting the right person or building leadership from within, this conversation gives you a proven framework to do it right. You'll also learn how mindset can reshape a team's success. Todd explains how to stay solution-oriented, even when facing adversity or toxic work environments. With real-life stories and insights, he shows how energy, emotional intelligence, and vision can turn roadblocks into stepping stones for growth. Whether you're aiming to break into medical sales or level up into a leadership role, this episode is packed with the strategies, tools, and mindset shifts you need. From hiring smarter to building future executives, Samuel and Todd deliver the blueprint to help you lead with purpose and drive real impact. Connect with Todd: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

This episode reveals how orthopedic surgery is being transformed, not by expensive robots or CT scans, but by smart, affordable navigation technology. Jerry Ennett, Senior Managing Partner at Intellijoint, joins us to share how their system is helping surgeons achieve precise hip and knee replacements while reducing costs and complexity. We explore how robotic systems like Mako are changing surgical strategy, not just in the OR, but in how surgeons attract patients and grow their practices. Jerry highlights real-world examples, including Dr. Marshall in Rhode Island, showing how technology becomes a competitive edge in both clinical outcomes and patient engagement. The conversation digs into the debate over accuracy, consistency, and personalized care. Jerry breaks down how Intellijoint ensures even the outlier patients who fall outside textbook ranges, receive the precision and reliability they need. It's a powerful case for why navigation systems are becoming essential, not optional. Looking ahead, we discuss the growing demand for smaller, faster, outpatient-friendly systems like the T-mini. Jerry shares how market shifts, patient expectations, and surgeon branding are all driving change and why sales professionals need to adapt if they want to succeed in this evolving space. If you're in medical sales, orthopedics, or just curious about how innovation reshapes industries, this episode is packed with insights that will sharpen your strategy and broaden your perspective. Connect with Jerry: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

How do you know if something needs prior authorization? Why does prior authorization take so long? What is electronic prior authorization? Discussing how to speed up prior authorization process using informatics in health care, HL7 and FHIR, computerized physician order entry, and more with Viet Nguyen, MD, chief standards implementation officer for HL7 International. American Medical Association CXO Todd Unger hosts.

Courtney Turich shares the journey of Cooler Heads, the startup behind a scalp cooling device that helps chemo patients keep their hair and dignity.   From early challenges to reaching over 100 infusion centers, she reveals how awareness, advocacy, and social media-fueled their growth.   We explore the emotional impact of scalp cooling, the barriers to oncologist adoption, and the company's commitment to patient education.   Courtney also offers career advice for breaking into medical sales, thriving in startups, and leading with purpose.   This is a must-listen for anyone who wants to build a mission-driven career, create a real impact in healthcare, or understand what it takes to grow a successful medical startup.   Connect with Courtney: LinkedIn Connect with Me: LinkedIn   Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

The Cybercrime Wire, hosted by Scott Schober, provides boardroom and C-suite executives, CIOs, CSOs, CISOs, IT executives and cybersecurity professionals with a breaking news story we're following. If there's a cyberattack, hack, or data breach you should know about, then we're on it. Listen to the podcast daily and hear it every hour on WCYB. The Cybercrime Wire is brought to you Cybercrime Magazine, Page ONE for Cybersecurity at https://cybercrimemagazine.com. • For more breaking news, visit https://cybercrimewire.com

From Clunky to Cutting-Edge: The Evolution of Airway Clearance with Nicole DunnWhen our daughters first received their vest machines, they felt like they weighed a hundred pounds and had to be plugged into the wall. The vests didn't fit well—riding high in the armpits and leaving much to be desired in comfort and function. Fast forward 25 years, and everything has changed.In this episode, Laura talks with Nicole Dunn, Senior Market Development and Education Manager at Tactile Medicaland an expert on the AffloVest. With a strong background as a registered respiratory therapist and a deep passion for respiratory education, Nicole is at the forefront of innovation in airway clearance therapy.Together, they dive into the evolution of the AffloVest—from its design improvements to the company's mission to provide accessible, life-changing therapy for people with chronic respiratory diseases like cystic fibrosis. Nicole shares how patient feedback has shaped product development, the impact of CF modulators on airway clearance, and how community engagement plays a vital role in Tactile Medical's approach.This episode is full of inspiration, real-life success stories, and a look at how far we've come in improving comfort, mobility, and quality of life for people with CF.To learn more about Tactile Medical please visit:  https://tactilemedical.comTo learn more about AffloVest:  https://affloVest.comFor questions: afflovestinfo@tactilemedical.com Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Physician Tina Stankovic is an ear, nose, and throat specialist and a lover of music whose seemingly disparate pursuits — medicine and music — have led her to a groundbreaking career in hearing research. She recently worked with music legend Paul Simon during his well-publicized battle with hearing loss and he has become a vocal advocate for hearing research. New understandings and new approaches like regenerative medicine have put the once-impossible dream of hearing restoration within reach, Stankovic tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Konstantina M. StankovicStanford Researchers Assist Paul Simon with his Return to the StageInside the Stanford Initiative to Cure Hearing Loss: Cutting-Edge Science and InnovationConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Tina Stankovic, a professor of otolaryngology and neurosurgery at Stanford University.(00:03:36) Why Hearing LossWhat inspired Tina's lifelong journey into hearing science.(00:04:17) Treating Hearing LossLimits of current options and lack of FDA-approved therapies.(00:05:23) Causes of Hearing LossThe two main categories of hearing loss: conductive vs. sensorineural.(00:07:47) Inside the Inner EarThe complexity of the inner ear, and why diagnosis is so difficult.(00:09:22) Tinnitus & Hearing LossWhy ear damage can cause phantom sounds in the brain.(00:10:28) Emerging Technologies in Hearing ResearchNew technologies that are evolving treatment approaches.(00:15:19) Recreating the Ear in the LabChallenges the inner ear's unique composition pose to researchers.(00:20:02) AI Applications in Hearing DiagnosisThe ways AI is transforming diagnosis and genetic analysis.(00:21:31) Can Ears Regrow?Why humans don't regenerate ear cells—but mice might help.(00:23:55) Emotional & Social Toll of Hearing LossHow hearing loss can lead to isolation, stigma, and cognitive decline.(00:26:06) Born Deaf vs. Later Hearing LossExperiential differences between those with early and late hearing loss.(00:27:52) Paul Simon's Role and AdvocacyHow the artist got involved with Tina's work and the initiative at Stanford.(00:29:44) Protecting Your HearingBest practices for protecting your hearing.(00:33:21) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

www.YourHealth.orgwww.SCHomeRx.comwww.thedisruptedpodcast.comwww.experiencinghealthcare.com

Struggling to stand out in medical sales? This episode is your blueprint for crafting a resume that gets noticed, even if you don't have direct sales experience.  Learn how to position your background as an asset, highlight your sales potential, and structure your resume for maximum impact. We'll also dive into LinkedIn strategies to boost your visibility and connect with decision-makers, plus real success stories from professionals who made the leap. If you're serious about breaking into medical sales, this episode is a must-listen! Connect with me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

The intersection of cybersecurity and healthcare is more critical than ever, as technology continues to shape the way patient care is delivered. At HIMSS 2025 in Las Vegas, we sat down with Lee Kim, Senior Principal of Cybersecurity and Privacy at HIMSS, to discuss the pressing security challenges facing healthcare organizations, the role of artificial intelligence, and the balance between innovation and risk.AI in Healthcare: Promise and PerilArtificial intelligence is rapidly being adopted across the healthcare sector, yet many organizations still lack structured governance around its use. Kim highlights the “wild west” nature of AI adoption, where policies are either non-existent or underdeveloped, creating risks related to privacy, data security, and patient outcomes. While AI-powered diagnostic tools, like those used in radiology, have the potential to improve patient care by identifying critical conditions early, blind trust in AI-generated results presents serious risks. Without proper oversight, reliance on AI could lead to incorrect medical decisions, putting patient safety in jeopardy.Cybersecurity Gaps in Healthcare OrganizationsOne of the biggest concerns in healthcare cybersecurity is the over-reliance on security tools without a clear strategy. Many organizations invest in the latest technology but neglect foundational security practices, such as governance, policy development, and staff training. Kim points out that less than half of cybersecurity budgets are allocated to governance, leading to disorganized security programs.Another persistent challenge is the human factor. Social engineering and phishing attacks remain the top attack vectors, exploiting the inherent culture of healthcare professionals who are trained to help and trust others. Organizations must focus on proactive security measures, such as regular training and simulated attacks, to reduce human error and strengthen defenses.The Financial and Operational RealityBudget constraints continue to be a challenge, particularly for smaller hospitals and community healthcare providers. While larger organizations may have more resources, cybersecurity spending often focuses on acquiring new tools rather than optimizing existing defenses. Kim stresses the importance of a balanced approach—investing in both technology and governance to ensure long-term resilience.Another concern is the increasing dependence on third-party services and cloud-based AI tools. If these services become too expensive or go offline, healthcare organizations may face operational disruptions. The lack of contingency planning, such as backup vendors or alternative systems, leaves many institutions vulnerable to supply chain risks.Building a More Resilient Healthcare Security ModelAs technology continues to drive innovation in healthcare, organizations must adopt a proactive cybersecurity stance. Business impact analyses, vendor risk assessments, and tabletop exercises should be standard practice to prepare for disruptions. Kim also raises the idea of cyber mutual aid—a model similar to emergency medical mutual aid, where healthcare organizations collaborate to support each other in times of crisis.HIMSS 2025 provides a forum for these critical conversations, bringing together global healthcare leaders to share insights, challenges, and solutions. For those interested in diving deeper, the HIMSS Cybersecurity Survey is available online, offering a comprehensive look at the current state of healthcare security.To hear the full discussion on these topics and more, listen to the episode featuring Lee Kim, Sean Martin, and Marco Ciappelli from HIMSS 2025 On Location.Guest: Lee Kim, Senior Principal of Cybersecurity and Privacy at HIMSS | On LinkedIn: https://www.linkedin.com/in/leekim/Hosts:Sean Martin, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining CyberSecurity Podcast [@RedefiningCyber] | On ITSPmagazine:  https://www.itspmagazine.com/sean-martinMarco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society Podcast & Audio Signals Podcast | On ITSPmagazine: https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli____________________________This Episode's SponsorsHITRUST: https://itspm.ag/itsphitweb____________________________ResourcesLearn more and catch more stories from HIMSS 2025 coverage: https://www.itspmagazine.com/himss-2025-health-technology-and-cybersecurity-event-coverage-las-vegasHIMSS 2024 Cybersecurity Report: https://www.himss.org/resources/himss-healthcare-cybersecurity-survey/____________________________Catch all of our event coverage: https://www.itspmagazine.com/technology-and-cybersecurity-conference-coverageTo see and hear more Redefining CyberSecurity content on ITSPmagazine, visit: https://www.itspmagazine.com/redefining-cybersecurity-podcastTo see and hear more Redefining Society stories on ITSPmagazine, visit:https://www.itspmagazine.com/redefining-society-podcastWant to tell your Brand Story Briefing as part of our event coverage? Learn More

This episode covers:In this episode, we discuss the #1 most overlooked factor in healing the thyroid, why thyroid medication may not be working for you, the importance of recovery over management, and so much more.Dr. Eric Balcavage DC, CFMP, BCIM, is the owner and founder of Rejuvagen. Dr. Balcavage is widely recognized around the world as a leader in Functional Medicine and Thyroid Physiology. In over 20 years of practice, he has successfully helped thousands of people suffering with thyroid problems and other chronic health conditions.Dr. Balcavage received his Doctorate of Chiropractic from Palmer College of Chiropractic Davenport, Iowa in 1995, and has been in practice since 1996. He also holds a Bachelor of Science in Medical Technology. Dr. Balcavage is Board Certified in Integrative Medicine, a Certified Functional Medicine Practitioner and a Certified Nutrition Specialist. He spends hundreds of hours every year advancing his knowledge base on functional medicine, thyroid physiology, functional neurology, immune system function, hormone function, and regenerative therapies. Dr. Balcavage's quest for advanced research and training is the result of his passion and determination to help patients who have been unable to heal and recover from chronic illness in the Allopathic medical model.Links mentioned during this episode:Why Isn't My Thyroid Medication Working? Ebook: https://rejuvagencenter.com/free-ebook-download/Free Initial Consultation with Dr. Megan: https://p.bttr.to/3a9lfYkLyons' Share Instagram: www.instagram.com/thelyonsshareJoin Megan's Newsletter: www.thelyonsshare.org/newsletter

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

What separates top-performing medical sales reps from the rest?  It's not just talent; it's elite training. Amy Harrington, VP of Clinical Training, reveals how the right approach to learning can make or break your success in this industry. Inside this episode: How Amy went from surgical tech to nurse to top-tier medical sales leader Why sales training isn't optional—it's the secret weapon for dominating the field The overlooked power of personalized learning in high-stakes industries How startups shaped her ability to adapt, innovate, and build winning teams Whether you aim to break in, level up, or reinvent your career, this episode delivers the insider playbook for thriving in medical sales. Meet the guest:  Amy Harrington is the Vice President of Clinical Training and Practice Development at R2 Technologies, Inc., where she leads the company's clinical education and advancement strategies. With over a decade of experience in the aesthetic and medical technology industries, Amy is known for designing innovative training programs that equip sales teams to sell confidently through science and knowledge. Since joining R2 in 2021, Amy has been a driving force behind the company'scompany's growth and innovation. Her strategic leadership—first as Director of Clinical Development & Education, then as Senior Director of Clinical Development, and now as VP of Practice Development—has been instrumental in establishing the R2 brand within clinical practices. Her contributions reflect a deep commitment to advancing the field of aesthetics through education and collaboration. Before R2, Amy held impactful leadership roles at Syneos Health, Obagi, and Solta Medical, where she developed and implemented transformative clinical and sales training programs. Beginning her career as a Registered Nurse in the operating room, she gained invaluable hands-on experience that continues to inform her practical and patient-centered approach to clinical education. Amy's academic background includes a dual bachelor's Degree in nursing and biology from the University of Maine, as well as an associate's Degree in criminalistics. She further enhanced her expertise in curriculum development with an instructional design certification from the Association of Talent Development. Outside of her professional endeavors, Amy is a wellness enthusiast who enjoys yoga, rowing, and exploring Maine's landscapes. A proud dog mom, she embraces an active outdoor lifestyle while balancing her passion for transforming clinical education with her love for the outdoors.  Connect with her:  LinkedIn Instagram

In this episode of the EMJ Podcast, host Jonathan Sackier welcomes William Lombardi, one of the leading innovators in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). They explore his groundbreaking work in CTO technology, the development of the hybrid algorithm, and lessons interventional cardiologists can learn from aviation safety.  Lombardi also shares insights into reducing practitioner risk, the mental resilience required in high-stakes medicine, and what drives his passion for innovation.  This is a must-listen for anyone interested in advancing cardiology, operator safety, and medical innovation.    Timestamps:  (00:00) - Introduction (01:50) - The story behind ‘Lioness' and family time on the water (06:15) - Learning from aviation: improving safety in PCI (11:14) - Changing the mindset in interventional cardiology (20:10) - The hybrid algorithm and its impact on CTO PCI (27:35) - From idea to market: innovating over 20 CTO technologies (35:14) - Reducing risk for interventional cardiologists (38:37) - The importance of mental health in performance (44:00) - Three wishes for the future of healthcare 

In this episode, Mark Beran, a seasoned medical device executive, discusses hi journey from working in his father's startup to leading sales and marketing teams in global medical device companies. Mark shares insights on team building, strategy execution, and the importance of having a connected and motivated workforce. He also touches on the challenges and opportunities presented by AI and regulations in the medical device industry. Listeners will gain valuable tips for driving organizational success and fostering a positive work environment. Episode Highlights: 02:23 Mark’s Career Journey 10:40 Leadership Insights and Turnaround Strategies 20:42 Challenges and Trends in the Medical Industry Mark Beran is a dynamic executive driving sales, marketing, and product development for a $250M leader in hospital textiles and patient safety products. He led M&A strategy, restructured sales for growth, and reversed a seven-year revenue decline. Mark spearheaded go-to-market strategies for new products, securing clinical advisory boards and marketing tools. His innovation leadership resulted in multiple patents, including a groundbreaking patient warming solution in a $3B market and advancements in Therapeutic Support Surfaces. With a focus on strategy, efficiency, and innovation, Mark combines vision and execution to drive business growth and transform patient care solutions. Connect with Mark: Company Website: www.starboardmedical.com LinkedIn: https://www.linkedin.com/in/markberan/ For more insights: Book a call: https://bit.ly/4cToGDs Follow me on my YouTube Channel: https://bit.ly/47GgMdn Sign up for my Weekly Newsletter: https://bit.ly/3T09kVcSee omnystudio.com/listener for privacy information.

Episode 13: Prime Directive Why didn't Hologram Janeway try harder to stop the kids from breaking the Prime Directive? Is the damage already done to the Enterprizian society? Why didn't Starfleet send down a negotiator to Solum after first contact? If Starfleet doesn't have the manpower to make first contact, should they stop? What does the Ouroboros symbol represent in this finale? Join Ashlyn and Rhianna as we discuss these questions and more Prodigy Prime Directive episode. This is the thirteenth episode of the Prime Directive series, where Ashlyn and Rhianna talk about the good and bad examples in every Star Trek show, discussing every Star Trek series. SPOILER WARNING: Prodigy seasons 1 & 2 TRIGGER WARNINGS: Civil war, bombs, and violence of war. Next week, we'll finish the Prime Directive series with Lower Decks! DISCLAIMER: We do not own any of the rights to Star Trek or its affiliations. This content is for review only. Our intro and outro is by Jerry Goldsmith. Rule of Acquisition #208: “Sometimes the only thing more dangerous than a question is an answer.” Please check out our Patreon and donate any $1, $6, $10, or $20 per month to access exclusive episodes of trivia, Galaxy Quest, and reviews of every episode of The Animated Series and our reviews of Lower Decks seasons 1-4! https://www.patreon.com/thedurassisterspodcast

Imagine a future in which Band-Aids talk to your cells, pacemakers are powered by light and your gut microbiome gets a tune-up—all thanks to tiny bioelectric devices. Sounds like sci-fi, right? Think again. Prof. Bozhi Tian of the University of Chicago is on the frontier of bioelectronics, building living machines that can heal, enhance and maybe even transform what it means to be human. In this episode, he explains his research lab's work and explores the thrilling, strange and sometimes unsettling world in which biology meets technology.

(3:10) - The Snake That Saves LivesThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about how medical robots have been evolving over the years and what the future looks like! Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

In this engaging conversation on the Crazy Wisdom podcast, Stewart Alsop talks with neurologist Brian Ahuja about his work in intraoperative neurophysiological monitoring, the intricate science of brainwave patterns, and the philosophical implications of advancing technology. From the practical applications of neuromonitoring in surgery to broader topics like transhumanism, informed consent, and the integration of technology in medicine, the discussion offers a thoughtful exploration of the intersections between science, ethics, and human progress. Brian shares his views on AI, the medical field's challenges, and the trade-offs inherent in technological advancement. To follow Brian's insights and updates, you can find him on Twitter at @BrianAhuja.Check out this GPT we trained on the conversation!Timestamps00:00 Introduction to the Crazy Wisdom Podcast00:21 Understanding Intraoperative Neurophysiological Monitoring00:59 Exploring Brainwaves: Alpha, Beta, Theta, and Gamma03:25 The Impact of Alcohol and Benzodiazepines on Sleep07:17 The Evolution of Remote Neurophysiological Monitoring09:19 Transhumanism and the Future of Human-Machine Integration16:34 Informed Consent in Medical Procedures18:46 The Intersection of Technology and Medicine24:37 Remote Medical Oversight25:59 Real-Time Monitoring Challenges28:00 The Business of Medicine29:41 Medical Legal Concerns32:10 Alternative Medical Practices36:22 Philosophy of Mind and AI43:47 Advancements in Medical Technology48:55 Conclusion and Contact InformationKey InsightsIntraoperative Neurological Monitoring: Brian Ahuja introduced the specialized field of intraoperative neurophysiological monitoring, which uses techniques like EEG and EMG to protect patients during surgeries by continuously tracking brain and nerve activity. This proactive measure reduces the risk of severe complications like paralysis, showcasing the critical intersection of technology and patient safety.Brainwave Categories and Their Significance: The conversation provided an overview of brainwave patterns—alpha, beta, theta, delta, and gamma—and their connections to various mental and physical states. For instance, alpha waves correspond to conscious relaxation, while theta waves are linked to deeper relaxation or meditative states. These insights help demystify the complex language of neurophysiology.Transhumanism and the Cyborg Argument: Ahuja argued that humans are already "cyborgs" in a functional sense, given our reliance on smartphones as extensions of our minds. This segued into a discussion about the philosophical and practical implications of transhumanism, such as brain-computer interfaces like Neuralink and their potential to reshape human capabilities and interactions.Challenges of Medical Technology Integration: The hype surrounding medical technology advancements, particularly AI and machine learning, was critically examined. Ahuja highlighted concerns over inflated claims, such as AI outperforming human doctors, and stressed the need for grounded, evidence-based integration of these tools into healthcare.Philosophy of Mind and Consciousness: A recurring theme was the nature of consciousness and its central role in both neurology and AI research. The unresolved "hard problem of consciousness" raises ethical and philosophical questions about the implications of mimicking or enhancing human cognition through technology.Trade-offs in Technological Progress: Ahuja emphasized that no technological advancement is without trade-offs. While tools like CRISPR and mRNA therapies hold transformative potential, they come with risks like unintended consequences, such as horizontal gene transfer, and the ethical dilemmas of their application.Human Element in Medicine: The conversation underscored the importance of human connection in medical practice, particularly in neurology, where patients often face chronic and emotionally taxing conditions. Ahuja's reflections on the pitfalls of bureaucracy, private equity in healthcare, and the overemphasis on defensive medicine highlighted the critical need to prioritize patient-centered care in an increasingly technological and administrative landscape.

Equipped with a degree from The University of Tulsa and the experience of working with his father, Dan P. Holmes, in his insurance business, Holmes and Chester Cadieux co-founded QuikTrip Corporation in 1958. QuikTrip has grown to one of the country's most successful convenience store networks.Later, he established Burt B. Holmes and Associates, the predecessor of The Holmes Organisation Inc., which he sold in 1998, but remains as a consultant.In 2010, The University of Tulsa's Collins College of Business named Holmes the Outstanding Entrepreneur for his dedication to life-long learning, entrepreneurship, and support for the arts, education, and community.He is president and director of Leaders Life Insurance Company, the American Institute of Medical Technology and National Occupational Health Services.Previously Holmes served as founder, owner or director of: Hurricane Trading Company, Gas Energy Development Co., Day Schools Inc., Healthfood Associates/Akin's, Utica National Bank, and National Bank of Commerce. He promoted Tulsa's first high-rise suburban office building, the Southland Financial Center.Holmes is past chairman and director emeritus of The University of Tulsa's board of trustees, past chairman and director of the Gilcrease Museum Association, The University of Tulsa Alumni Association and Family and Children's Services, former director of the Tulsa Philharmonic, Palmer Drug Abuse Program, Thornton Family YMCA, Greenwood Cultural Center, and Phillips Theological Seminary.Currently, he serves as a director of the Tulsa Botanic Garden and First Oklahoma Bank.

On this episode of The Medical Alley Podcast, we chat with Stephanie Kent, the President & CEO of Carbon Medical Technologies (CMT). Stephanie details how her professional experience allows her to ask the right questions, CMT's work with pyrolytic carbon in the medical device sector (including its Durosphere product), how CMT navigates regulatory challenges when bringing products to market, and much more.The 2025 Medical Alley Summit is just around the corner. Learn more about this year's event and secure your seat here.Send us a message! Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

Hosts Gil Bashe and Gregg Masters welcome Walter Greenleaf, PhD, Stanford University MediaX Program Innovator. They discuss applied innovations in AI, virtual reality and intersection of healthcare and technology. Dr. Greenleaf is a neuroscientist and a medical technology developer working at Stanford University. With over three decades of research and development experience, Dr. Greenleaf is a leading authority in the field of digital medicine and medical virtual reality technology. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Is AI About to Replace Your Doctor? Or Save Your Life? The tools that are reshaping healthcare will redefine medicine—and your life—in ways you've never imagined. Will artificial intelligence and regenerative therapies like stem cells and exosomes make doctors obsolete? Or will they finally unlock the secrets to living to 180? In this episode, Dave sits down with Dr. Pradeep Albert, a leader in regenerative medicine and AI-driven imaging, to explore the intersection of technology, longevity, and healing. Dr. Albert shares groundbreaking insights on how AI is revolutionizing medical diagnostics, replacing outdated systems, and empowering patients to take control of THEIR OWN health. He also dives deep into regenerative therapies—how PRP, exosomes, and stem cells are changing the game for injuries, inflammation, and aging. Can AI improve patient-doctor relationships? Are doctors becoming coaches instead of gatekeepers? And most importantly, how can you leverage these tools to outlive your peers and enhance every aspect of your health? What You'll Learn: • Why 50% of people won't make it past 76—and how to beat the odds • How AI is already better than doctors at diagnosing certain conditions • The truth about PRP, exosomes, and stem cells—and when to use each • The three rules of longevity every person needs to know • How your mindset and epigenetics can help you live longer and healthier Resources: 2025 Biohacking Conference – https://biohackingconference.com/2025 Dr. Pradeep Albert's Book: Exosomes, PRP, and Stem Cells…Medicine – https://www.amazon.com/Exosomes-Stem-Cells-Musculoskeletal-Medicine/dp/B0C2S59S8K Dr. Pradeep Albert's Book: Lifespan Decoded –https://lifespandecoded.com/ Dr Pradeep Albert's Website – https://drpradeepalbert.com/ Danger Coffee – https://dangercoffee.com Dave Asprey's Website – https://daveasprey.com Dave Asprey's Book: Smarter Not Harder – https://daveasprey.com/books Dave Asprey's Linktree – https://linktr.ee/daveasprey Upgrade Collective: Join The Human Upgrade Podcast Live – https://www.ourupgradecollective.com Own an Upgrade Labs – https://ownanupgradelabs.com Upgrade Labs – https://upgradelabs.com 40 Years of Zen – Neurofeedback Training for Advanced Cognitive Enhancement – https://40yearsofzen.com Sponsors: ARMRA | Go to https://tryarmra.com/ and use the code DAVE to get 15% off your first order. OneSkin | Go to https://oneskin.co/ and use code ASPREY15 for 15% off your purchase. Timestamps: • 00:00 – Introduction to AI in Medicine • 00:36 – The Role of AI in Longevity • 00:51 – Meet Dr. Pradeep Alpert • 01:11 – AI's Impact on Healthcare • 02:07 – Changing Role of Doctors • 05:01 – AI in Medical Imaging • 06:37 – Orthopedics and AI • 09:19 – Longevity and Epigenetics • 14:16 – The Importance of Mindset • 29:08 – Trust in the Medical System • 43:18 – DIY Health and Longevity • 44:21 – The Future of Insurance and Medical Costs • 45:45 – Advancements in Imaging Technology • 47:26 – The Art of Physical Examination • 50:21 – Regenerative Medicine: PRP, Exosomes, and Stem Cells • 01:00:23 – Challenges in the US Medical System • 01:07:54 – The Role of AI in Medicine • 01:18:14 – Final Thoughts and Book Promotion See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Navigation Technology in Sinus Surgery for Improved Patient Outcomes Dr. Reddy and Dr. Smith discuss the innovative world of navigation-assisted sinus surgery in this episode of We Knows Noses. They explain how this cutting-edge technology enhances safety, precision, and patient education, allowing for more thorough and effective sinus procedures. The doctors also discuss the evolution of navigation tools from operating rooms to office-based procedures, making advanced sinus treatments accessible and cost-effective.     What you'll learn: How navigation-assisted technology improves surgical precision and safety The benefits of office-based sinus procedures with navigation systems How augmented reality and real-time visualization support thorough sinus care   Tune in to discover how navigation technology is reshaping sinus surgery for better patient outcomes and enhanced safety! Make sure to subscribe for more ENT content and visit or website at njent.com.

Today, I am blessed to have Dr. Eric Balcavage here with me. He is the owner and founder of Rejuvagen. Dr. Balcavage is widely recognized around the world as a leader in Functional Medicine and Thyroid Physiology. In over 20 years of practice, he has successfully helped thousands of people suffering from thyroid problems and other chronic health conditions. Dr. Balcavage received his Doctorate of Chiropractic from Palmer College of Chiropractic Davenport, Iowa in 1995 and has been in practice since 1996. He also holds a Bachelor of Science in Medical Technology. Dr. Balcavage is Board Certified in Integrative Medicine, a Certified Functional Medicine Practitioner, and a Certified Nutrition Specialist. He spends hundreds of hours every year advancing his knowledge base on functional medicine, thyroid physiology, functional neurology, immune system function, hormone function, and regenerative therapies. Dr. Balcavage's quest for advanced research and training is the result of his passion and determination to help patients who have been unable to heal and recover from chronic illness in the Allopathic medical model. Dr. Balcavage has studied under and consulted with several experts in Functional Medicine over the years, including renowned thyroid expert Dr. Datis Kharrazian and methylation expert Dr. Ben Lynch. Dr. Balcavage trains and consults with hundreds of doctors on topics such as Thyroid physiology, GI physiology, Organic acid testing, and Methylation. He also lectures locally and around the country on numerous other health conditions. His Functional Medicine Center has always been on the cutting edge of health care and science. Currently, he devotes his practice to treating patients with thyroid disorders, gastrointestinal disorders, diabetes/ insulin resistance, autoimmune & inflammatory disorders, and other metabolic challenges. In this episode, Dr. Balcavage dives into the intricate world of thyroid physiology and its profound impact on overall health. Focusing on understanding thyroid allostasis, he challenges conventional perspectives on thyroid dysfunction, emphasizing the role of adaptive responses to cellular stress. Dr. Balcavage explores the potential for thyroid recovery, advocating for a nuanced approach to medication use and highlighting the body's remarkable capacity for healing and adaptation. Additionally, he explores the intricate interplay between thyroid hormone, mitochondrial function, and cellular stress adaptation, shedding light on the complexities of maintaining optimal thyroid health.  Resources from this episode:  Rejuvagen: https://rejuvagencenter.com/ The Thyroid Debacle: https://amzn.to/3DalW7K  Thyroid Answers Podcast: https://podcasts.apple.com/us/podcast/thyroid-answers-podcast/id1189585193 Follow Dr. Eric Balcavage Instagram: https://www.instagram.com/drericbalcavage/ Facebook: https://www.facebook.com/rejuvagencenter/ YouTube: https://www.youtube.com/user/askdrbalcavage

How is technology shaping the future of neurosurgery? In this episode, Bill sits down with Dr. Lawton, President and CEO of Barrow Neurological Institute, Robert F. Spetzler Endowed Chair for Neurosciences, and Chair of the Department of Neurosurgery. Dr. Lawton discusses the ways he is bringing new technologies and innovation to neurosurgery, as well as how it could improve patients outcomes and broaden the field's scope of impact.---------Key Quotes:“If we're able to have these huge datasets where we can take all the brain tumor patients and then go back 10 years before they were ever diagnosed and see what was abnormal then, it might open up these ways to predict or diagnose or even prevent some of these diseases before they get started.” “It's a technological revolution that has all of a sudden allowed us to envision things in neurosurgery that incorporate this tech in ways that we never had 20 years ago… I think probably the best example of that is the brain computer interface. There's the perfect example  of how technology and engineering brought into neurosurgery is going to change the world.”“Instead of taking just six variables, we can take a hundred variables and we can feed them into the black box of AI, and we can look at way more than just those six. And maybe our decision making will be better. Maybe our predictive powers will be different.”--------Timestamps: (02:26) Integrating technology in neurosurgery(06:37) Brain-Computer Interfaces (09:56) Expanding neurosurgical training(19:09) AI in neurosurgery: Diagnostics and beyond(29:16) Mysteries of the Mind and understanding the mind(34:35) Future of neurosurgery in emotional and cognitive interventions--------Sponsor:Edge solutions are unlocking data-driven insights for leading organizations. With Dell Technologies, you can capitalize on your edge by leveraging the broadest portfolio of purpose-built edge hardware, software and services. Leverage AI where you need it; simplify your edge; and protect your edge to generate competitive advantage within your industry. Capitalize on your edge today with Dell Technologies.--------Credits:Over the Edge is hosted by Bill Pfeifer, and was created by Matt Trifiro and Ian Faison. Executive producers are Matt Trifiro, Ian Faison, Jon Libbey and Kyle Rusca. The show producer is Erin Stenhouse. The audio engineer is Brian Thomas. Additional production support from Elisabeth Plutko.--------Links:Watch Dr. Lawton share his vision for how AI and edge solutions can be used to transform neurosurgeryFollow Dr. Lawton on X and InstagramLearn more about Barrow Neurological Institute and neurosurgeryGet to know Barrow President and CEO Michael T. Lawton, MDDiscover more about Barrow Neurological Institute's newest research quest to solve the mysteries of the mindWatch Dr. Lawton operate in this collection of neurosurgical operative videosFind out what it's like to be a neurosurgeon by watching three seasons of Barrow Neurosurgery Base CampFollow Barrow Neurological Institute on YouTube, Instagram, LinkedIn, X and FacebookFollow Bill on LinkedIn

YouTube Description:In this insightful discussion, we dive deep into the Jesse Brown VA Telehealth Services with Camille Masten, the facility's Technical Telehealth Coordinator. Discover how Telehealth is transforming the way veterans receive care, making it more accessible and convenient. Camille shares the history of Telehealth at Jesse Brown VA, its evolution since 2012, and how it has expanded, especially during the COVID-19 pandemic. Learn about the services offered, the technology used, and how Telehealth is ensuring veterans receive the right care at the right time. Whether you're a veteran, a family member, or simply interested in telemedicine, this video provides a comprehensive look at the future of healthcare for veterans. Don't miss out on understanding how these services could benefit you or someone you know.Timestamps: Introduction to the esteemed panelist Camille Masten Overview of Jesse Brown VA Telehealth ServicesHow Telehealth Supports Veterans' Healthcare NeedsThe Evolution and Expansion of Telehealth at Jesse Brown VAFamily Services and Telehealth BenefitsThe Coordination and Management of Telehealth ServicesFuture of Telehealth and Innovations at Jesse Brown VACamille's Vision for the Expansion of Telehealth Services Keywords: Jesse Brown VA, Telehealth, Veterans Healthcare, Telemedicine, Camille Masten, VA Services, Virtual Care, Healthcare Technology, Veteran Benefits, COVID-19, Telehealth Expansion, Family Services, Medical Technology.

Extracorporeal membrane oxygenation, or ECMO, can be a lifesaving technology for patients whose organs have failed. It works, essentially, by performing the functions that a healthy person's lungs and heart would normally do. While using the machine, many recipients of ECMO treatment can walk, talk, even ride a stationary bike, but they can't leave the hospital with the machine, nor can they survive without it. In a recent article in The New Yorker, emergency physician and writer Clayton Dalton described these patients as “caught on a bridge to nowhere.” Marketplace's Lily Jamali spoke to Dalton about the complicated ethics of this technology.

Extracorporeal membrane oxygenation, or ECMO, can be a lifesaving technology for patients whose organs have failed. It works, essentially, by performing the functions that a healthy person's lungs and heart would normally do. While using the machine, many recipients of ECMO treatment can walk, talk, even ride a stationary bike, but they can't leave the hospital with the machine, nor can they survive without it. In a recent article in The New Yorker, emergency physician and writer Clayton Dalton described these patients as “caught on a bridge to nowhere.” Marketplace's Lily Jamali spoke to Dalton about the complicated ethics of this technology.

Extracorporeal membrane oxygenation, or ECMO, can be a lifesaving technology for patients whose organs have failed. It works, essentially, by performing the functions that a healthy person's lungs and heart would normally do. While using the machine, many recipients of ECMO treatment can walk, talk, even ride a stationary bike, but they can't leave the hospital with the machine, nor can they survive without it. In a recent article in The New Yorker, emergency physician and writer Clayton Dalton described these patients as “caught on a bridge to nowhere.” Marketplace's Lily Jamali spoke to Dalton about the complicated ethics of this technology.